(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.87%87.31M | -16.00%47.45M | -5.97%25.45M | -23.20%7.96M | 282.23%76.67M | 818.67%56.49M | 422.96%27.06M | 167.90%10.37M | 1.71%20.06M | -59.01%6.15M |
Operating income | 13.87%87.31M | -16.00%47.45M | -5.97%25.45M | -23.20%7.96M | 282.23%76.67M | 818.67%56.49M | 422.96%27.06M | 167.90%10.37M | 1.71%20.06M | -59.01%6.15M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Administrative expenses | 1.03%-52.34M | 71.23%-11.54M | 72.75%-5.61M | 62.84%-3.33M | -127.60%-52.88M | -338.57%-40.1M | -209.13%-20.58M | -161.43%-8.97M | 18.62%-23.24M | 53.71%-9.14M |
Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---12.04M | ---10.77M | ---- | ---- | ---- |
Employee expense | 28.36%-5.21M | 24.46%-3.92M | 11.63%-3.37M | 26.21%-1.34M | 6.46%-7.27M | 21.69%-5.19M | 22.00%-3.81M | 38.04%-1.82M | 69.30%-7.77M | 66.48%-6.62M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.90%-195.99M | 105.18%10.95M |
-Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.90%-195.99M | 105.18%10.95M |
Impairment and provision | -24.78%-2.97M | --2.63M | --2.63M | ---- | 77.58%-2.38M | ---- | ---- | ---- | 89.98%-10.6M | 51.68%-9.22M |
-Other impairment is provision | -24.78%-2.97M | --2.63M | --2.63M | ---- | 77.58%-2.38M | ---- | ---- | ---- | 89.98%-10.6M | 51.68%-9.22M |
Special items of operating profit | 105.72%260K | 57.14%11K | 100.00%8K | -50.00%1K | 90.49%-4.55M | -69.57%7K | -81.82%4K | -90.00%2K | -477.35%-47.83M | -97.73%23K |
Operating profit | 182.04%27.05M | 4,253.84%34.64M | 336.35%19.12M | 890.63%3.29M | 103.61%9.59M | 89.39%-834K | 12.66%-8.09M | 42.14%-416K | 45.80%-265.37M | 96.91%-7.86M |
Financing cost | 33.33%-48K | -665.00%-153K | -425.00%-105K | 90.91%-1K | 68.42%-72K | 79.38%-20K | 79.38%-20K | 85.14%-11K | 80.74%-228K | 89.84%-97K |
Earning before tax | 183.67%27.01M | 4,138.64%34.49M | 334.47%19.01M | 870.02%3.29M | 103.58%9.52M | 89.27%-854K | 13.35%-8.11M | 46.15%-427K | 45.88%-265.6M | 96.88%-7.96M |
Tax | -51.39%-10.14M | -86.61%-9.87M | -118.82%-4.99M | -97,000.00%-971K | -74,344.44%-6.7M | -58,644.44%-5.29M | -25,222.22%-2.28M | 88.89%-1K | -100.04%-9K | -100.11%-9K |
After-tax profit from continuing operations | 497.94%16.86M | 500.98%24.62M | 235.01%14.02M | 641.36%2.32M | 101.06%2.82M | 22.93%-6.14M | -10.90%-10.39M | 46.63%-428K | 43.53%-265.6M | 96.77%-7.97M |
Earning after tax | 497.94%16.86M | 500.98%24.62M | 235.01%14.02M | 641.36%2.32M | 101.06%2.82M | 22.93%-6.14M | -10.90%-10.39M | 46.63%-428K | 43.53%-265.6M | 96.77%-7.97M |
Minority profit | -129.77%-64K | -111.48%-21K | -83.70%15K | ---- | 165.55%215K | 158.28%183K | 136.80%92K | 138.46%45K | 79.78%-328K | 82.04%-314K |
Profit attributable to shareholders | 549.75%16.93M | 489.71%24.65M | 233.69%14.01M | 589.85%2.32M | 100.98%2.61M | 17.38%-6.32M | -14.95%-10.48M | 30.95%-473K | 43.40%-265.28M | 96.88%-7.65M |
Basic earnings per share | 308.24%0.307 | 370.26%0.4935 | 225.12%0.3786 | 589.05%0.067 | 100.98%0.0752 | -4,050.00%-0.1826 | -5,609.43%-0.3026 | -3,325.00%-0.0137 | -2,729.89%-7.6605 | 96.89%-0.0044 |
Diluted earnings per share | 308.24%0.307 | 370.26%0.4935 | 225.12%0.3786 | 589.05%0.067 | 100.98%0.0752 | -4,050.00%-0.1826 | -5,609.43%-0.3026 | -3,325.00%-0.0137 | -2,729.89%-7.6605 | 96.89%-0.0044 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data